GOED chairman: Serious omega-3 supply issues lie ahead as demand rockets

By Shane Starling in Hong Kong

- Last updated on GMT

Related tags: Eicosapentaenoic acid, Omega-3 fatty acid

GOED chairman: Serious omega-3 supply issues lie ahead as demand rockets
The chair of the international marine-sourced omega-3 trade group has warned the omega-3 sector faces an impending supply crisis as global demand booms for food, pharma and supplement products.

Talking with NutraIngredients today at the Vitafoods Asia event in Hong Kong, Baldur Hjaltason, EPAX strategic business development executive and chairman of the Global Organisation for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) Omega-3 (GOED), said already maxed-out fish stocks are going to struggle to meet omega-3 oil demand forecast at ongoing 7-8% annual growth by market analyst, Frost & Sullivan.

“The main fisheries in Morocco and Peru are near capacity, so you have to ask the question: Where is the omega-3 going to come from if it keeps growing as it forecast to? Algal oils may be able deliver more but can they deliver the high dose EPA oils that are increasingly being demanded by the pharma sector? But there are algal oil companies transferring their energies from biofuels to omega-3 oils so that offers some potential.”

“There is also plant research going on but that might be 10 to 15 years before it reaches commercially viable levels, so the industry has a problem it needs to tackle now.”

Supply pressure

At Frost & Sullivan forecast growth rates, the 2011 global omega-3 oil output of 110,000 tonnes will increase by 8000 tonnes per year, with further pressure being put on this figure by the rise of pharma demand, which requires more raw oil to deliver the high-purity doses required in that sector.

There may be excess capacity in US menhaden fisheries, Hjaltason observed, but again, this source did not deliver oils with high-dose potential and hence was used mostly for animal feed.

Other research such as that into fungus being conducted by DuPont also was a long way from delivering anything of commercial value.

Price pressure

Hjaltason warned the situation could lead to an omega-3 oil price hike from exiting levels of about $2300-$2500 per tonne for refined oils, that may ward off potential manufacturer interest.

That said, fish oil specialist EPAX had no intention to buy into the algal sector, but was scrutinising the market for potential supply partners.

“We will be a buyer of algal oils when it is economically viable. We would rather pursue this strategy as it offers us more flexibility.”

Hjaltason also noted a trend where Chinese suppliers were shifting production to the US so that oils could be sold back into China and other countries as “Made in the USA”.

Related news

Show more

Related products

show more

The Ingredients Show 2019 NEC Birmingham

The Ingredients Show 2019 NEC Birmingham

William Reed | 01-Jan-2019 | Product Brochure

We’ve been bringing food and drink markets together for over 150 years. And the drive to
inform and serve our sectors that fuelled the launch of...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Omegavie® DHA algae Capsules

Omegavie® DHA algae Capsules

POLARIS | 23-Aug-2018 | Application Note

Omegavie® DHA algae capsules is a real opportunity to consume high-performing Omega-3 DHA 100% vegan, natural, sustainable, GMO- and allergen-free. Designed...

Related suppliers

Follow us

Featured Events

View more


View more